U.S. Markets close in 5 hrs 58 mins

Alector, Inc. (0Z2.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
11.50-0.20 (-1.71%)
As of 8:45AM CEST. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close11.70
Open11.50
Bid11.30 x 0
Ask11.60 x 0
Day's Range11.50 - 11.50
52 Week Range11.50 - 11.50
Volume50
Avg. VolumeN/A
Market Cap809.791M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.04
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Hedge Funds Are Piling Into Alector, Inc. (ALEC)
    Insider Monkey

    Hedge Funds Are Piling Into Alector, Inc. (ALEC)

    At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). We reversed our stance on March 25th after seeing unprecedented fiscal and monetary stimulus unleashed by the Fed and the Congress. […]

  • Alector's (NASDAQ:ALEC) Shareholders Are Down 32% On Their Shares
    Simply Wall St.

    Alector's (NASDAQ:ALEC) Shareholders Are Down 32% On Their Shares

    Investors can approximate the average market return by buying an index fund. When you buy individual stocks, you can...

  • GlobeNewswire

    Alector to Participate at Virtual Investor Conferences in September

    SOUTH SAN FRANCISCO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that members of management will participate in fireside chats at the following upcoming virtual investor conferences: * Citi’s 15th Annual BioPharma Virtual Conference, Thursday, September 10, 2020, at 11:40 a.m. ET * Morgan Stanley 18th Annual Global Healthcare Conference, Monday, September 14, 2020, at 12:00 p.m. ETLive webcasts of each fireside chat will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.alector.com. Replays of the webcasts will be available on the Alector website for 30 days following the event.About AlectorAlector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. Alector is developing a broad portfolio of programs designed to functionally repair genetic mutations that cause dysfunction of the brain’s immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. The Company’s product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer’s disease. Alector is headquartered in South San Francisco, California. For additional information, please visit www.alector.com.Contacts Media: Erica Jefferson Vice President, Communications and Public Affairs Alector, Inc. 301-928-4650 erica.jefferson@alector.com1AB Dan Budwick 973-271-6085 dan@1abmedia.comorInvestors: Alector, Inc. ir@alector.com